Home › Phenylketonuria › Illinois › Chicago
Phenylketonuria clinical trials in Chicago, IL
5 studies for Phenylketonuria are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
PheCheck™ Validation Study
RecruitingObservational study
- Lurie Children's Hospital, Chicago
A Study of JNT-517 in Participants With Phenylketonuria (PKU)
RecruitingPhase 3
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Immune Modulation During Palynziq® Treatment in Adults (IMPALA)
RecruitingPhase 4
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)
RecruitingObservational study
- Northwestern University, Chicago
A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)
RecruitingObservational study
- Northwestern University, Chicago
About Phenylketonuria
In phenylketonuria (PKU), your body can't process phenylalanine, an amino acid in most foods. Read about genetics, screening, and special diets.
More about Phenylketonuria on MedlinePlus
Phenylketonuria trials in other cities
- Dallas, TX7 studies
- Pittsburgh, PA6 studies
- Indianapolis, IN6 studies
- Portland, OR5 studies
- Salt Lake City, UT4 studies
- Atlanta, GA4 studies
- Boston, MA3 studies
- Tampa, FL3 studies
- Nashville, TN3 studies
- Aurora, CO3 studies
- Milwaukee, WI3 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer61 studies
- Breast Cancer58 studies
- Cancer (all types)51 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Obesity41 studies
- Lung Cancer41 studies
- Ovarian Cancer36 studies
- Stroke34 studies
- Colorectal Cancer33 studies
- Heart Failure31 studies
- Overweight28 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.